Shih-Wei Chiang

Dr. Shih-Wei Chiang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2025 in Cancers
Verified
Journal Article
Open access
PDF file
CLChun-Yu Lin
Chun-Yu Lin
YLYi-Chun Liu
Yi-Chun Liu
CCChou-Chen Chen
Chou-Chen Chen
MCMing-Cheng Chen
Ming-Cheng Chen
TCTeng-Yi Chiu
Teng-Yi Chiu
FCFENG FAN CHIANG
FENG FAN CHIANG
Background and Objective: Colorectal cancer (CRC) is the third most common cancer worldwide, with colon cancer accounting for approximately 60% of all CRC cases. Surgery remains the primary and most effective treatment. Robotic-assisted surgery (RAS) has emerged as a promising approach for colon cancer resection. This retrospective study compares RAS and laparoscopic-assisted surgery (LSS) for stage I–III colon cancer resections at a single medical center in East Asia. Methods: Between 1 January 2018, and 29 February 2024, patients undergoing colectomy were classified into right-side and left-side colectomies. Propensity score matching was conducted based on age group, gender, ASA score, and BMI to ensure comparability between groups. After matching, there were 50 RAS and 200 LSS cases for right colectomy (RC), and 129 RAS and 258 LSS cases for left colectomy (LC). Perioperative outcomes were compared between the two surgical approaches. The primary outcomes were recovery milestones, while secondary outcomes included complications and postoperative pain scores. Results: RAS demonstrated faster recovery milestones compared to LSS (hospital stay: 6.5 vs. 10.2 days, p = 0.005 for RC; 5.5 vs. 8.2 days, p < 0.001 for LC). RAS also resulted in lower rates of ileus (14% vs. 26%, p = 0.064 for RC; 6.2% vs. 15.9%, p = 0.007 for LC) and higher lymph node yields (31.4 vs. 26.8, p = 0.028 for RC; 25.8 vs. 23.9, p = 0.066 for LC). Major complication rates showed no significant difference between RAS and LSS (4.0% vs. 7.0%, p = 0.746 for RC; 4.7% vs. 3.1%, p = 0.563 for LC). Patients in the RAS group experienced earlier diuretic phases and reported significantly lower postoperative pain scores (3.0 vs. 4.1, p = 0.011 for RC; 2.9 vs. 4.1, p < 0.001 for LC). Conclusions: Robotic-assisted surgery is associated with faster recovery, lower rates of ileus (LC), higher lymph node yield (RC) and reduced postoperative pain compared to laparoscopic-assisted surgery for colon cancer resection.

1 January 2024 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
SCShih-Wei Chiang
Shih-Wei Chiang
Background: Colorectal cancer (CRC) is a common malignancy, especially among older adults. Inflammation has been implicated in cancer progression, making inflammatory indices potential prognostic markers. This study aimed to evaluate the prognostic significance of the Glasgow prognostic score (GPS), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/C-reactive protein ratio (LCR), and C-reactive protein/albumin ratio (CAR) in older adults with CRC. Methods: This population-based, retrospective observational study included patients aged ≥ 65 years with colorectal adenocarcinoma who were admitted to Taichung Veterans General Hospital (Chiayi branch) between 2017 and 2022. Demographic and clinicopathological characteristics, and results of inflammatory indices were collected from medical records for all patients. Receiver operating characteristic (ROC) curve analyses were performed to determine the optimal cutoffs of the inflammatory indices in predicting overall mortality. Associations between the inflammatory indices, overall survival (OS) and progression-free survival (PFS) were determined using univariate and multivariable Cox proportional hazard regression analyses, with model performance evaluated using the C-index. Results: Data of 106 patients were analyzed. After adjusting for confounders, GPS ≥ 1 (vs 0) significantly predicted poor OS (adjusted hazard ratio [aHR]: 3.80, 95% confidence interval [CI]: 1.30– 11.10, p= 0.015, C-index= 0.825) and PFS (aHR: 3.19, 95% CI: 1.34– 7.57, p= 0.008, C-index= 0.785). CAR ≥ 1.0 (vs < 1) significantly predicted poor OS (aHR: 2.36, 95% CI: 1.01– 5.48), p=0.046, C-index= 0.825) and PFS (aHR: 2.33, 95% CI: 1.14– 4.76, p= 0.020, C-index= 0.786). Conclusion: Among hospitalized older adults with CRC in Taiwan, high GPS and CAR, but not NLR, PLR or LCR, are potentially useful prognostic indicators for poor OS and PFS.

31 January 2022 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
SCShih-Wei Chiang
Shih-Wei Chiang
TCTzu-Wei Chiang
Tzu-Wei Chiang
Introduction and importance: The most common symptoms of primary gastrointestinal (GI) lymphoma are non-specific, such as nausea, vomiting, diarrhea, weight loss, and abdominal pain. The rare acute symptoms include bowel obstruction, intussusception, and perforation. Primary small bowel lymphoma accounts for the smallest proportion of all GI malignancies. We report a case of intestinal lymphoma presenting with bloody stools and anemia. Case presentation: The patient initially underwent both duodenoscopy and colonoscopy with negative findings. Isotopic red blood cell (RBC) scan was then performed due to persistent bleeding along with computed tomography angiography (CTA) because of suspected bleeding in the left abdomen. Successful embolization over the arcade of the sigmoid and left colic arteries was performed. However, the bleeding did not stop, and ischemic colitis was diagnosed by repeat colonoscopy. A coloenteric fistula was finally discovered during emergent laparotomy. Clinical discussion: GI lymphomas are a rare disease entity among the all GI malignancies. Despite acute abdominal symptoms including obstruction, perforation, bleeding and intussusception, enteral fistula is also one of the complications. It was seen to be a long-term complication after treatment or disease process in most of cases, however it could occur as the initial manifestation. GI bleeding is a life-threatening condition and commonly needs prompt decision making. There were no standard managements for these patients, it depends on clinical judgements from physician individually. Conclusion: This is a rare condition that has not been previously described in Taiwan. Early diagnosis and timely management will decrease morbidity and mortality in the GI lymphoma population. Highlights:

28 February 2026 in Cancers
Verified
Journal Article
Open access
PDF file
YTYu Kang Tseng
Yu Kang Tseng
CLChangLin Lin
ChangLin Lin
SCShih-Wei Chiang
Shih-Wei Chiang
FCFENG FAN CHIANG
FENG FAN CHIANG
Background: Taiwan’s transition to a super-aged society presents challenges in managing elderly patients with refractory metastatic colorectal cancer (mCRC). This study evaluated the real-world effectiveness of trifluridine/tipiracil (FTD/TPI) plus bevacizumab versus regorafenib in this specific geriatric population. Methods: A retrospective study analyzed patients aged ≥ 65 treated between 2019 and 2023. Patients received regorafenib (n = 46) or FTD/TPI plus bevacizumab (n = 35). Primary endpoints included overall survival (OS) and time to treatment failure (TTF). Results: FTD/TPI plus bevacizumab was associated with significantly longer median OS compared to regorafenib (12.5 vs. 6.5 months; p = 0.039). In multivariate analysis, the combination regimen was identified as an independent predictor of favorable TTF (adjusted HR 0.44, 95% CI 0.22–0.91, p = 0.028). Regorafenib was associated with symptomatic toxicities like hand–foot skin reaction (58.7%), while the combination primarily caused asymptomatic neutropenia. Crucially, permanent discontinuation due to adverse events was significantly lower in the combination arm (2.9% vs. 30.4%, p < 0.001), facilitating a higher proportion of patients receiving subsequent systemic therapy (45.7% vs. 17.4%, p = 0.011). Conclusions: FTD/TPI plus bevacizumab is associated with improved survival outcomes and better tolerability than regorafenib. By demonstrating a manageable safety profile and minimizing treatment attrition, this regimen ensures a sustainable continuum of care, representing a favorable therapeutic option for elderly patients.

17 June 2026 in Biotechnology and Bioengineering
Verified
Journal Article
Open access
SCShih-Wei Chiang
Shih-Wei Chiang
CYChuan‐Yi Yang
Chuan‐Yi Yang
GCGuan-Yu Chen
Guan-Yu Chen
The intestinal epithelium and its resident microbiota form a dynamic interface that is central to gut homeostasis, but this interface is difficult to model with conventional tools. Static Transwell cultures lack physiological fluid shear, whereas animal models are costly and poorly suited to quantitative, high‐content imaging. Organ‐on‐a‐chip technology offers a way to recreate key physical and biological features of the gut, yet many existing gut‐on‐chip systems remain technically demanding or poorly standardized for routine use. Here, we developed and validated a practical gut‐on‐chip workflow that enables reproducible, imaging‐based quantification of epithelial barrier dynamics during short‐term co‐culture with Escherichia coli . Using a commercial two‐channel microfluidic chip and Caco‐2 cells, we first established a perfused intestinal model under low‐flow conditions (0.5–1 µL/min) and confirmed long‐term stability by phase‐contrast imaging, LIVE/DEAD staining, and immunofluorescence for ZO‐1, F‐actin, and wheat germ agglutinin (WGA). This protocol generated a confluent, polarized monolayer with continuous tight junctions and an apical glycoprotein mucus layer. We then introduced HADA‐labeled E. coli and systematically varied the perfusion rate during co‐culture. At 0.5 µL/min, the epithelial layer, although stable in monoculture, underwent rapid thinning and focal detachment within 4 days of co‐culture, indicating that low shear is insufficient to buffer bacterial overgrowth and metabolite accumulation. In contrast, Caco‐2 monolayers tolerated perfusion up to 10 µL/min without structural damage, and at this higher flow rate we achieved a stable, 24‐h analytical window in which epithelial integrity and bacterial distribution could be imaged reliably. Structural disruption only became evident when co‐culture was extended to four and 7 days. Taken together, these results identify perfusion rate as the decisive parameter for stabilizing host–microbe co‐culture on a gut‐on‐chip platform. The workflow described here couples a functionally validated epithelial barrier with an experimentally simple, yet robust, perfusion regime. It provides an accessible test‐bed for quantitative studies of early host–microbe interactions and can be readily extended with orthogonal barrier readouts, such as TEER or tracer permeability, in future work.